
Cozen O’Connor announced that veteran litigator Michael Osborne joined its fast-growing Commercial Litigation practice group as a member in the firm’s Toronto office. Michael, who has extensive experience defending leading pharmaceutical, banking and technology enterprises in class actions alleging price fixing and other high-stakes litigation, will also chair the firm’s new Canadian Antitrust practice group.
As the 16th lawyer to join the firm’s Vancouver and Toronto offices since June 2021, Michael’s addition continues the firm’s ongoing expansion in Canada, as well as it’s continual buildout of its Commercial Litigation department. At Cozen O’Connor, Michael will counsel and defend clients in inquiries and proceedings initiated by Canada’s Competition Bureau, including criminal matters, abuse of dominance, and marketing and advertising matters. He will also counsel clients on obtaining approvals for mergers under the Competition Act and the Investment Canada Act.
“Michael’s antitrust practice is national in scope and fits the strategic objectives of our Toronto and Vancouver offices like a glove. His addition gives us a new practice area in Canada — competition — and also enhances the firm’s commercial litigation services, both in Canada and the United States,” said James H. Heller, co-chair of the firm’s Commercial Litigation Department. “As a trial lawyer with substantial experience in regulatory matters, particularly competition/antitrust and other commercial disputes, he brings a cross-border pedigree that’s vitally important to our Canadian clients. I’m excited to welcome him to the firm and our department.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas